Netherlands· NL-be26a4e3fcdf

Vyndaqel 20 mg zachte capsules

A tafamidis product containing tafamidismeglumine, registered in Netherlands by Pfizer Europe MA EEIG. The same ATC class is registered in 17 of our 19 countries.

ATC N07XX08

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about tafamidismeglumineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Tafamidis is registered in 17 of 19 countries.

Countries holding a registration under ATC N07XX08 (tafamidis), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
9 of them publish a price we can compare per daily dose

Search tafamidis products by name

Tafamidis · ATC N07XX08

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Japan
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of tafamidis costs, country by country.

Normalised to the WHO defined daily dose (20 mg), the median price runs from $0.082 in France to $118.78 in Switzerland — a ×1457 gap.

2 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Tafamidis · price per daily dose (20 mg)

USD · FX 28 Sept 2026

CH Switzerland$118.78
FR France$0.082

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: TAFAMIDISMEGLUMINE
Manufacturer: Pfizer Europe MA EEIG
Country: Netherlands (NL)
ATC code: N07XX08
ATC class: Tafamidis
Defined daily dose: 20 mg, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
EU/1/11/717

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

18 interactions on record for tafamidis.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check tafamidis against other medicines How interaction checks work

Tafamidis · interactions on record

18 records

2 severe
16 moderate

Most severe, free to view

OzanimodL04AA38severe
OzanimodL04AE02severe
EltrombopagB02BX05moderate
LusutrombopagB02BX07moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tafamidis in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tafamidis products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

Austria · Tafamidis Stada, Tafamidis Viatris
Belgium · Tafamidis Viatris
Germany · Tafamidis Al, Tafamidis Viatris
Spain · Tafamidis Stada, Tafamidis Viatris
France · Tafamidis Biogaran, Tafamidis Eg
United Kingdom (Northern Ireland) · Tafamidis Thornton & Ross
Iceland · Vyndaqel
Liechtenstein · Vyndaqel
Norway · Tafamidis Stada Nordic, Tafamidis Viatris
Sweden · Tafamidis Stada Nordic, Tafamidis Viatris
Slovenia · Tafamidis Sumar

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/d115ae4b-78c3-4c9e-8bb4-d90e2383f84c
GET /v1/drugs/d115ae4b-78c3-4c9e-8bb4-d90e2383f84c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, zacht",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/vyndaqel-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Tafamidis",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp108223",
  "excipients": [
    "AMMONIA (E 527)",
    "BRILJANTBLAUW FCF (E 133)",
    "GELATINE (E 441)",
    "GLYCEROL (E 422)",
    "IJZEROXIDE GEEL (E 172)",
    "KARMIJN (E120)",
    "MACROGOL 400",
    "MACROGOL 400",
    "MANNITOL (D-) (E 421)",
    "PAARSE INKT",
    "POLYSORBAAT 80 (E 433)",
    "PROPYLEENGLYCOL (E 1520)",
    "SORBITAN",
    "SORBITANMONOOLEAAT (E 494)",
    "SORBITOL (E 420)",
    "TITAANDIOXIDE (E 171)",
    "WATER, GEZUIVERD"
  ],
  "substances": [
    "TAFAMIDISMEGLUMINE"
  ],
  "leaflet_url": null,
  "authorised_at": "2011/11/16",
  "procedure_number": "EMEA/H/C/002294",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/11/717",
  "additional_monitoring": "Y"
}

API reference MCP server Plans

See everything about tafamidis.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console